Display options
Share it on

Front Pediatr. 2017 Mar 02;5:33. doi: 10.3389/fped.2017.00033. eCollection 2017.

Feasibility of a Peer-Led Asthma and Smoking Prevention Project in Australian Schools with High Indigenous Youth.

Frontiers in pediatrics

Gabrielle B McCallum, Anne B Chang, Cate A Wilson, Helen L Petsky, Jan Saunders, Susan J Pizzutto, Siew Choo Su, Smita Shah

Affiliations

  1. Child Health Division, Menzies School of Health Research, Charles Darwin University , Darwin, NT , Australia.
  2. Child Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia; Children's Health Queensland, Queensland University of Technology, Brisbane, QLD, Australia.
  3. Children's Health Queensland, Queensland University of Technology , Brisbane, QLD , Australia.
  4. Asthma Foundation NT , Darwin, NT , Australia.
  5. Primary Health Care Education and Research Unit, Western Sydney Local Health District , Sydney, NSW , Australia.

PMID: 28303238 PMCID: PMC5332358 DOI: 10.3389/fped.2017.00033

Abstract

BACKGROUND: The high global burden of asthma and tobacco smoking among Indigenous people may potentially be reduced by appropriate interventions that target prevention of tobacco smoke uptake and improved asthma management. The latter includes targeted treatment based on airway inflammation. We undertook a feasibility study in two Darwin schools with a high proportion of Indigenous youth to determine the feasibility of an innovative, peer-led, school-based education program called the Asthma and Smoking Prevention Project (ASPP). A subset of children with reported persistent respiratory symptoms were also clinically evaluated to determine the lower airway inflammatory profile and optimize asthma management.

METHODS: The ASPP is founded on an evidence-based three-step program and targets improving asthma management and preventing the uptake of tobacco smoking. The program uses a student-centered approach in which senior students (peer leaders) deliver the ASPP to Grade 7 students using activities, videos, and games. Students completed questionnaires related to asthma and smoking at baseline and 3 months after program delivery. Students with respiratory symptoms at 3 months were invited for a comprehensive clinical evaluation and tests including sputum induction.

RESULTS: The ASPP was well received. Of the 203 students involved, 56 (28%) were Indigenous and 70% completed baseline and follow-up questionnaires. Self-reported asthma was high (19%), 10% of students reported smoking and 63% reported exposure to tobacco at home. Of the 22 students who were clinically evaluated, 41% were Indigenous. Clinically important airway inflammation was high; 23% had Fractional Exhaled Nitric Oxide Levels ≥35 ppb, 88% had airway neutrophilia (>15%), and 29% had airway eosinophilia (>2.5%). Optimization of medication and management was required in 59% of students.

CONCLUSION: Our study has demonstrated the implementation of the ASPP was well received by the schools as well as by the students. The high prevalence of clinically important airway inflammation and suboptimal asthma management highlights the need for a community-based study on persistent respiratory symptoms in adolescents to reduce the burden of chronic lung disease particularly for Indigenous Australians.

Keywords: Indigenous; adolescent; airway inflammation; asthma; school-based service; tobacco smoking

References

  1. J Paediatr Child Health. 2000 Jun;36(3):249-51 - PubMed
  2. Clin Exp Allergy. 2000 Aug;30(8):1181-7 - PubMed
  3. BMJ. 2001 Mar 10;322(7286):583-5 - PubMed
  4. Arch Dis Child. 2002 Apr;86(4):270-5 - PubMed
  5. Eur Respir J Suppl. 2002 Sep;37:44s-46s - PubMed
  6. BMJ. 2004 Mar 27;328(7442):759-62 - PubMed
  7. Curr Opin Allergy Clin Immunol. 2007 Feb;7(1):102-6 - PubMed
  8. Thorax. 2007 Dec;62(12):1034-6 - PubMed
  9. Prog Lipid Res. 2009 Jan;48(1):27-43 - PubMed
  10. Aust Fam Physician. 2008 Nov;37(11):952-4 - PubMed
  11. Curr Opin Pulm Med. 2009 Jan;15(1):39-45 - PubMed
  12. Tob Induc Dis. 2009 Mar 26;5(1):6 - PubMed
  13. Thorax. 2009 May;64(5):369-70 - PubMed
  14. Med J Aust. 2009 May 18;190(10):530-1 - PubMed
  15. Int J Equity Health. 2009 Oct 31;8:37 - PubMed
  16. Cochrane Database Syst Rev. 2010 May 12;(5):CD006344 - PubMed
  17. Thorax. 2012 Mar;67(3):199-208 - PubMed
  18. Am J Respir Crit Care Med. 2011 Sep 1;184(5):602-15 - PubMed
  19. Pediatrics. 2012 Jan;129(1):e106-12 - PubMed
  20. Chest. 2012 Oct;142(4):943-950 - PubMed
  21. Cochrane Database Syst Rev. 2012 Aug 15;(8):CD009325 - PubMed
  22. BMC Public Health. 2012 Nov 10;12:963 - PubMed
  23. Allergy. 2013 Mar;68(3):402-6 - PubMed
  24. Eur Respir J. 2013 Oct;42(4):1012-9 - PubMed
  25. Pediatrics. 2013 May;131(5):e1576-83 - PubMed
  26. Cochrane Database Syst Rev. 2013 Apr 30;(4):CD001293 - PubMed
  27. Paediatr Child Health. 2012 Aug;17(7):376-80 - PubMed
  28. J Paediatr Child Health. 2014 Apr;50(4):286-90 - PubMed
  29. Chest. 2014 Jun;145(6):1271-1278 - PubMed
  30. BMC Public Health. 2014 Dec 17;14:1296 - PubMed
  31. Allergy Asthma Proc. 2014 Nov-Dec;35(6):454-61 - PubMed
  32. Int J Environ Res Public Health. 2015 Jan 15;12(1):841-54 - PubMed
  33. Med J Aust. 2015 Feb 16;202(3):125-6 - PubMed
  34. Lancet Respir Med. 2015 Mar;3(3):188-9 - PubMed
  35. PLoS One. 2015 Jun 12;10(6):e0129517 - PubMed
  36. BMC Public Health. 2015 Jul 13;15:648 - PubMed
  37. BMC Public Health. 2016 Jan 11;16:21 - PubMed
  38. Cochrane Database Syst Rev. 2017 Aug 22;8:CD006580 - PubMed
  39. Eur Respir J. 1988 May;1(5):428-32 - PubMed
  40. Lancet. 1996 Aug 31;348(9027):567-72 - PubMed
  41. J Adolesc Health. 1998 Jan;22(1):66-72 - PubMed
  42. Eur Respir J. 1998 Feb;11(2):462-6 - PubMed
  43. Eur Respir J. 1998 Apr;11(4):848-53 - PubMed

Publication Types